HRMY : Insider Transactions for Harmony Biosciences Holdings, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Harmony Biosciences Holdings, Inc. (HRMY)

$0.00 0.00 (0.00%) as of 4:30 Tue 11/30

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

63,680,000

Market Cap:

N/A

Last Volume:

0

Avg Vol:

0

52 Week Range:

$ - $

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -

Company Profile Harmony Biosciences is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological disorders. Co.'s product, WAKIX (pitolisant), is a first-in-class molecule with a novel mechanism of action, specifically designed to increase histamine signaling in the brain by binding to H3 receptors. WAKIX is used for the treatment of excessive daytime sleepiness (EDS), in adult patients with narcolepsy, focusing on the treatment of EDS associated with Prader-Willi Syndrome and myotonic dystrophy. Co. is also exploring pitolisant for treatments in other rare neurological disorders affected by fatigue and cognitive impairments.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	12,173	12,173	12,173	2,968,359
Total Sell Value	$389,536	$389,536	$389,536	$166,425,443
Total People Sold	1	1	1	6
Total Sell Transactions	2	2	2	56
End Date	2024-01-25	2023-10-24	2023-04-25	2022-04-25

Adjust Filter Settings

Records found: 169

Page 1 of 7

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

CHIEF FINANCIAL OFFICER

• – –

2024-03-29

4

D

$33.58

$269,077

D/D

(8,013)

6,987

-

CHIEF FINANCIAL OFFICER

• – –

2024-03-29

4

OE

$0.00

$0

D/D

15,000

15,000

-

CHIEF COMMERCIAL OFFICER

• – –

2024-03-15

4

AS

$32.00

$383,328

D/D

(11,979)

0

-

CHIEF COMMERCIAL OFFICER

• – –

2024-03-15

4

OE

$8.22

$98,467

D/D

11,979

11,979

-

CHIEF COMMERCIAL OFFICER

• – –

2024-03-08

4

AS

$32.00

$6,208

D/D

(194)

0

-

CHIEF COMMERCIAL OFFICER

• – –

2024-03-08

4

OE

$8.22

$1,595

D/D

194

194

-

CHIEF MEDICAL OFFICER

• – –

2023-05-01

3

IO

$0.00

$0

D/D

0

1,005

-

– • –

2022-12-14

4

AS

$59.96

$169,927

I/I

(2,834)

2,571,024

-

Director

– • –

2022-12-14

4

S

$60.00

$7,800

I/I

(130)

2,147,943

-

Director

– • –

2022-12-13

4

S

$60.13

$380,022

I/I

(6,320)

2,148,073

-

Director

– • –

2022-12-12

4

S

$60.36

$1,351,521

I/I

(22,391)

2,154,393

-

– • –

2022-12-09

4

AS

$59.89

$589,737

I/I

(9,847)

2,573,858

-

– • –

2022-12-08

4

AS

$59.90

$2,208,992

I/I

(36,878)

2,583,705

-

– • –

2022-12-07

4

AS

$60.35

$3,863,969

I/I

(64,026)

2,620,583

-

Director

– • –

2022-12-05

4

S

$61.23

$4,766,939

I/I

(77,853)

2,176,784

-

CHIEF STRATEGY OFFICER

• – –

2022-12-02

4

AS

$60.12

$2,285,100

D/D

(38,000)

0

-

CHIEF STRATEGY OFFICER

• – –

2022-12-02

4

OE

$8.22

$312,360

D/D

38,000

38,000

-

– • –

2022-12-01

4

AS

$60.00

$3,939,120

I/I

(65,652)

2,684,609

-

– • –

2022-11-30

4

AS

$58.93

$2,514,366

I/I

(42,667)

2,750,261

-

– • –

2022-11-29

4

AS

$57.82

$1,233,474

I/I

(21,333)

2,792,928

-

Director

– • –

2022-11-22

4

AS

$57.60

$1,837,555

I/I

(31,902)

2,814,261

-

Director

– • –

2022-11-21

4

AS

$57.08

$1,421,178

I/I

(24,898)

2,846,163

-

Director

– • –

2022-11-18

4

AS

$57.00

$1,185,600

I/I

(20,800)

2,871,061

-

Director

– • –

2022-11-15

4

S

$60.10

$658,756

I/I

(10,961)

2,254,637

-

Director

– • –

2022-11-15

4

AS

$56.80

$3,574,594

I/I

(62,933)

2,891,861

-

169 Records found	1 2 3 4 5 6 7	Page 1 of 7

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.